| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_08af0384f6f51dec690acc32530c81be |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-557 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-557 |
| filingDate |
1990-10-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
1992-05-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ed4715abace8c07b3b939f04d1f4a8cb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_51c6f0e30b4cfa035f72c94fcd9824b9 |
| publicationDate |
1992-05-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-5114971-A |
| titleOfInvention |
Prostaglandin derivatives for the treatment of glaucoma or ocular hypertension |
| abstract |
11-epi PGF2 alpha esters are employed in treating glaucoma or ocular hypertension. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2004214806-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5221690-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7384926-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007225263-A1 |
| priorityDate |
1989-05-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |